Director Of Catalyst Pharmaceuticals Sold $5.22M In Stock

What caused the massive Google Cloud outage today? Why is Warner Bros. splitting up its media empire? How will BlackRock’s new targets affect asset management? What impact did the Air India Boeing 787 crash have? Why is Frito-Lay shutting down its Southern California plant? How are GOP plans affecting green energy tax credits? What caused the late dip in Bitcoin and crypto prices?

Director Of Catalyst Pharmaceuticals Sold $5.22M In Stock

benzinga.com/insights/news/25/06/45886612/director-of-catalyst-pharmaceuticals-sold-5-22m-in-stock

Revealing a significant insider sell on June 10, Patrick J McEnany, Director at Catalyst Pharmaceuticals CPRX, as per the latest SEC filing.
What Happened: McEnany opted to sell 200,000 shares of Catalyst Pharmaceuticals, according to a Form 4 filing with the U.S. Securities and Exchange…

This story appeared on benzinga.com, 2025-06-11 15:01:52.